ULTRAPLEX BIOANALYSIS LTD
Company number 15709451 · Active · Sandbach CW11 3SN
ULTRAPLEX BIOANALYSIS LTD is an active private limited company (company number 15709451) incorporated on 8 May 2024, registered in Sandbach. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 August 2025, showing net assets of −£83k, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public.
By net assets it sits in the bottom quarter of 278 comparable companies in Other (median £129, upper quartile £59k).
Key dates
- Incorporated
- 8 May 2024
- Next accounts due
- 31 May 2027 — in 225 days
- Confirmation statement due
- 22 May 2027 — in 216 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- Micro (Companies Act thresholds)
Financials — 1 period on record, latest ending 31 August 2025
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 August 2025 | −£83k | — | — | — | — | — | 2 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Firmoscan score: 39/100 (grade D)
- -15 Negative net assets — Net assets £-82,861 at 2025-08-31
- +4 Past first filings — Incorporated 2024-05-08
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Mr Howard Thomas Parker — owns 25–50% of shares; holds 25–50% of voting rights; can appoint or remove directors · since 8 May 2024
- Mrs Nicole Schacht Parker — owns 25–50% of shares; holds 25–50% of voting rights; can appoint or remove directors · since 8 May 2024
- Mr Kent Lindsay Parker — has significant influence or control · since 17 May 2024 · ceased 8 December 2024
- Mrs Nicola Anne Parker — has significant influence or control · since 17 May 2024 · ceased 8 December 2024
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in the UK
Same activity (research and experimental development on biotechnology), closest in incorporation date.
- NANO-WAVE LTD — Stirling, inc. May 2024
- BIONKOR HEALTH LTD — Dorchester, inc. Apr 2024
- JELLAGEN PHARMA LIMITED — Stirling, inc. May 2024
- RADNOMICS LIMITED — Norwich, inc. Apr 2024
- INTERNATIONAL LAB FOR INTERDISCIPLINARY RESEARCH — Mildenhall, inc. Apr 2024
- VENOMITE LTD — Chipping Campden, inc. Jun 2024
Reminders for ULTRAPLEX BIOANALYSIS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.